B-細胞激活因子(BAFF)重組蛋白
Recombinant B-Cell Activating Factor (BAFF)
CD257; TNFSF13B; BLYS; TALL1; THANK; TNFSF20; ZTNF4; B lymphocyte stimulator; Tumor Necrosis Factor Ligand Superfamily Member 13B; Dendritic cell-derived TNF-like
- 編號RPB686Ra01
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位n/a
- 預(yù)測分子量-
- 實際分子量-(差異分析請參閱說明書)
- 片段與標簽
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點-
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 840 ¥ 2100 ¥ 4200 ¥ 12600 ¥ 31500
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB686Ra01 | B-細胞激活因子(BAFF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB686Ra02 | B-細胞激活因子(BAFF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB686Ra01 | B-細胞激活因子(BAFF)多克隆抗體 | WB; IHC; ICC; IP. |
| MAB686Ra21 | B-細胞激活因子(BAFF)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB686Ra | B-細胞激活因子(BAFF)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB686Ra | B-細胞激活因子(BAFF)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| International Immunopharmacology | Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis [Pubmed:25598291] |
| Int Immunopharmacol | BAFF and its receptors involved in the inflammation progress in adjuvant induced arthritis rats [PubMed: 26688104] |
| Clinical Rheumatology | Metabolic syndrome in Sj [PubMed: 26370103] |
| Transplantation | Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model. [PubMed: 25919767] |
| Rheumatology? | Cortical bone density and thickness alterations by high-resolution peripheral quantitative computed tomography: association with vertebral fractures in primary … [rheumatology.kew332.abstract] |
| Clinical?Immunology | Toll-like receptor 9 ligands increase type I interferon induced B-cell activating factor expression in chronic rhinosinusitis with nasal polyposis [Pubmed:30056130] |
| Gene | A Significant Decrease of BAFF, APRIL, and BAFF Receptors Following Mesenchymal Stem Cell Transplantation in Patients with Refractory Rheumatoid Arthritis [Pubmed: 31935514] |
| american journal of physiology-renal physiology | The expression of XBP1s in B lymphocytes is critical for pristane-induced lupusnephritis in mice [Pubmed: 32249615] |
| diagnostics | Interstitial Score and Concentrations of IL-4R|á, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial??- [33924683] |
留言咨詢
